{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:45:11Z","timestamp":1785249911443,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012963","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000}}],"reference-count":75,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012963.pub2","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T10:13:05Z","timestamp":1569924785000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prostanoids and their analogues for the treatment of pulmonary hypertension in neonates"],"prefix":"10.1002","volume":"2019","author":[{"given":"Binoy","family":"Shivanna","sequence":"first","affiliation":[{"name":"Baylor College of Medicine; Section of Neonatology, Department of Pediatrics; One Baylor Plaza Houston Texas USA 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharada","family":"Gowda","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine; Section of Neonatology, Department of Pediatrics; One Baylor Plaza Houston Texas USA 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E","family":"Welty","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine; Section of Neonatology, Department of Pediatrics; One Baylor Plaza Houston Texas USA 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith J","family":"Barrington","sequence":"additional","affiliation":[{"name":"CHU Ste-Justine; Department of Pediatrics; 3175 Cote Ste Catherine Montreal QC Canada H3T 1C5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Pammi","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine; Section of Neonatology, Department of Pediatrics; One Baylor Plaza Houston Texas USA 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD012963.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41372-018-0179-7","article-title":"Intravenous epoprostenol improves oxygenation index in patients with persistent pulmonary hypertension of the newborn refractory to nitric oxide","volume":"38","author":"Ahmad","year":"2018 Sep","journal-title":"Journal of Perinatology"},{"issue":"9","key":"10.1002\/14651858.CD012963.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jpedsurg.2017.03.058","article-title":"Safety and tolerability of subcutaneous treprostinil in newborns with congenital diaphragmatic hernia and life-threatening pulmonary hypertension","volume":"52","author":"Carpentier","year":"2017","journal-title":"Journal of Pediatric Surgery"},{"issue":"2","key":"10.1002\/14651858.CD012963.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2007-984370","article-title":"Aerosolized iloprost in the treatment of pulmonary hypertension in extremely preterm infants: a pilot study","volume":"220","author":"Eifinger","year":"2008","journal-title":"Klinische Padiatrie"},{"issue":"1","key":"10.1002\/14651858.CD012963.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s002469900099","article-title":"Prostacyclin treatment for persistent pulmonary hypertension of the newborn","volume":"18","author":"Eronen","year":"1997","journal-title":"Pediatric Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD012963.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1067\/mpd.2002.129849","article-title":"Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide","volume":"141","author":"Kelly","year":"2002","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012963.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000298137","article-title":"Persistent pulmonary hypertension of the newborn successfully treated with beraprost sodium: a retrospective chart review","volume":"99","author":"Nakwan","year":"2011","journal-title":"Neonatology"},{"issue":"3","key":"10.1002\/14651858.CD012963.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jpeds.2015.06.016","article-title":"Short-term treprostinil use in infants with congenital diaphragmatic hernia following repair","volume":"167","author":"Olson","year":"2015","journal-title":"Journal of Pediatrics"},{"issue":"26","key":"10.1002\/14651858.CD012963.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"e7303","DOI":"10.1097\/MD.0000000000007303","article-title":"Treprostinil for persistent pulmonary hypertension of the newborn, with early onset sepsis in preterm infant: 2 case reports","volume":"96","author":"Park","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1002\/14651858.CD012963.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00383-008-2225-6","article-title":"Management of pulmonary hypertension in congenital diaphragmatic hernia: nitric oxide with prostaglandin-E1 versus nitric oxide alone","volume":"24","author":"Shiyanagi","year":"2008","journal-title":"Pediatric Surgery International"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/1745-6215-15-486","article-title":"Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials","volume":"15","author":"Sood","year":"2014","journal-title":"Trials"},{"issue":"4","key":"10.1002\/14651858.CD012963.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-0033-1348949","article-title":"Inhaled iloprost in preterm infants with severe respiratory distress syndrome and pulmonary hypertension","volume":"31","author":"Yilmaz","year":"2014","journal-title":"American Journal of Perinatology"},{"issue":"6","key":"10.1002\/14651858.CD012963.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-121-6-199409150-00003","article-title":"Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin","volume":"121","author":"Barst","year":"1994","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012963.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012963.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.CIR.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD012963.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","article-title":"Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging","volume":"187","author":"Bell","year":"1978","journal-title":"Annals of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD012963.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"e682","DOI":"10.1542\/peds.2011-1827","article-title":"Prospective analysis of pulmonary hypertension in extremely low birth weight infants","volume":"129","author":"Bhat","year":"2012","journal-title":"Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD012963.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/0022-3468(93)90431-J","article-title":"Persistent pulmonary hypertension in high-risk congenital diaphragmatic hernia patients: incidence and vasodilator therapy","volume":"28","author":"Bos","year":"1993","journal-title":"Journal of Pediatric Surgery"},{"issue":"3","key":"10.1002\/14651858.CD012963.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jped.2012.11.009","article-title":"Persistent pulmonary hypertension of the newborn: recent advances in pathophysiology and treatment","volume":"89","author":"Cabral","year":"2013","journal-title":"Jornal de Pediatria"},{"issue":"8","key":"10.1002\/14651858.CD012963.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archopht.1984.01040030908011","article-title":"An international classification of retinopathy of prematurity","volume":"102","author":"Committee for the Classification of Retinopathy of Prematurity","year":"1984","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD012963.pub2-BIB0020|cit20","first-page":"167","article-title":"Inhaled iloprost for severe persistent pulmonary hypertension of the newborn","volume":"90","author":"Chotigeat","year":"2007","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"2","key":"10.1002\/14651858.CD012963.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"5 Pt 2","key":"10.1002\/14651858.CD012963.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"H1474","DOI":"10.1152\/ajpheart.1992.262.5.H1474","article-title":"Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus","volume":"262","author":"Cornfield","year":"1992","journal-title":"American Journal of Physiology"},{"issue":"4","key":"10.1002\/14651858.CD012963.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1460-9592.2006.02104.x","article-title":"Iloprost as 'rescue' therapy for pulmonary hypertension of the neonate","volume":"17","author":"Luca","year":"2007","journal-title":"Paediatric Anaesthesia"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1742-1241.2008.01811.x","article-title":"Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension","volume":"160","author":"Doran","year":"2008","journal-title":"International Journal of Clinical Practice. Supplement"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"926968","DOI":"10.1155\/2012\/926968","article-title":"PGI2 as a regulator of inflammatory diseases","volume":"2012","author":"Dorris","year":"2012","journal-title":"Mediators of Inflammation"},{"issue":"4","key":"10.1002\/14651858.CD012963.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S1047951103000726","article-title":"Iloprost in persistent pulmonary hypertension of the newborn","volume":"13","author":"Ehlen","year":"2003","journal-title":"Cardiology in the Young"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0027|cit27","unstructured":"Extracorporeal Life Support Organization (ELSO) Guidelines for neonatal respiratory failure www.elso.org\/Portals\/0\/IGD\/Archive\/FileManager\/8588d1a580cusersshyerdocumentselsoguidelinesforneonatalrespiratoryfailure13.pdf 2013"},{"issue":"13","key":"10.1002\/14651858.CD012963.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1517\/14656560903164228","article-title":"Inhalative iloprost - pharmacology and clinical application","volume":"10","author":"Ewert","year":"2009","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD012963.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1183\/09031936.00097107","article-title":"Prostacyclin therapies for the treatment of pulmonary arterial hypertension","volume":"31","author":"Gomberg-Maitland","year":"2008","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0030|cit30","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0031|cit31","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD012963.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.amjcard.2006.09.119","article-title":"Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil","volume":"99","author":"Ivy","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD012963.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2007.09.031","article-title":"Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension","volume":"51","author":"Ivy","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD012963.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1097\/PCC.0b013e3181d10845","article-title":"Prostacyclin in the intensive care setting","volume":"11","author":"Ivy","year":"2010","journal-title":"Pediatric Critical Care Medicine"},{"issue":"25 Suppl","key":"10.1002\/14651858.CD012963.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"D117","DOI":"10.1016\/j.jacc.2013.10.028","article-title":"Pediatric pulmonary hypertension","volume":"62","author":"Ivy","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s13312-013-0263-1","article-title":"Effectiveness and safety of intravenous iloprost for severe persistent pulmonary hypertension of the newborn","volume":"50","author":"Janjindamai","year":"2013","journal-title":"Indian Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD012963.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia","volume":"163","author":"Jobe","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"12","key":"10.1002\/14651858.CD012963.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1440-1681.1997.tb02730.x","article-title":"Prostanoid action on the human pulmonary vascular system","volume":"24","author":"Jones","year":"1997","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"1","key":"10.1002\/14651858.CD012963.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.clp.2015.11.013","article-title":"Pulmonary hypertension and pulmonary vasodilators","volume":"43","author":"Keller","year":"2016","journal-title":"Clinics in Perinatology"},{"issue":"CD005494","key":"10.1002\/14651858.CD012963.pub2-BIB0040|cit40","article-title":"Sildenafil for pulmonary hypertension in neonates","author":"Kelly","year":"2017","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ndt\/15.1.43","article-title":"Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media?","volume":"15","author":"Koch","year":"2000","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD012963.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0095-5108(18)30039-3","article-title":"Pulmonary vascular biology during neonatal transition","volume":"26","author":"Lakshminrusimha","year":"1999","journal-title":"Clinics in Perinatology"},{"issue":"3","key":"10.1002\/14651858.CD012963.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.clp.2012.06.006","article-title":"The pulmonary circulation in neonatal respiratory failure","volume":"39","author":"Lakshminrusimha","year":"2012","journal-title":"Clinics in Perinatology"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.semperi.2015.12.004","article-title":"Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide","volume":"40","author":"Lakshminrusimha","year":"2016","journal-title":"Seminars in Perinatology"},{"issue":"4","key":"10.1002\/14651858.CD012963.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jpeds.2010.09.025","article-title":"Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension","volume":"158","author":"Levy","year":"2011","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD012963.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1124\/pr.111.004770","article-title":"Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn","volume":"64","author":"Majed","year":"2012","journal-title":"Pharmacological Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012963.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0952-3278(93)90105-6","article-title":"The pharmacokinetics and pharmacodynamics of the prostacyclin analog 15AU81 in the anesthetized beagle dog","volume":"48","author":"McNulty","year":"1993","journal-title":"Prostaglandins, Leukotrienes & Essential Fatty Acids"},{"issue":"2","key":"10.1002\/14651858.CD012963.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1542\/peds.2007-1583","article-title":"Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease","volume":"121","author":"Mourani","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012963.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1164\/rccm.201409-1594OC","article-title":"Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia","volume":"191","author":"Mourani","year":"2015","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012963.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1253\/circj.71.1785","article-title":"Efficacy and limitations of continuous intravenous epoprostenol therapy for idiopathic pulmonary arterial hypertension in Japenese children","volume":"71","author":"Nakayama","year":"2007","journal-title":"Circulation Journal"},{"issue":"4","key":"10.1002\/14651858.CD012963.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0095-5108(18)30030-7","article-title":"Blood pressure measurements in the newborn","volume":"26","author":"Nuntnarumit","year":"1999","journal-title":"Clinics in Perinatology"},{"issue":"2","key":"10.1002\/14651858.CD012963.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.pharmthera.2004.01.003","article-title":"Prostacyclin and its analogues in the treatment of pulmonary hypertension","volume":"102","author":"Olschewski","year":"2004","journal-title":"Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD012963.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm","volume":"92","author":"Papile","year":"1978","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012963.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamapediatrics.2013.866","article-title":"Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage","volume":"167","author":"Payne","year":"2013","journal-title":"JAMA Pediatrics"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/bcpt.13051","article-title":"Current and future treatments for persistent pulmonary hypertension in the newborn","volume":"123","author":"Pedersen","year":"2018","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"1","key":"10.1002\/14651858.CD012963.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.clp.2011.12.006","article-title":"Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents","volume":"39","author":"Porta","year":"2012","journal-title":"Clinics in Perinatology"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD012963.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1164\/ajrccm.157.6.9609017","article-title":"Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome","volume":"157","author":"Putensen","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012963.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.1985.tb07416.x","article-title":"An ultrastructural study of stored human platelets after washing using prostacyclin","volume":"60","author":"Read","year":"1985","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0059|cit59","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"14","key":"10.1002\/14651858.CD012963.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"issue":"7","key":"10.1002\/14651858.CD012963.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial","volume":"112","author":"Rubin","year":"1990","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1253\/circj.CJ-16-0097","article-title":"Efficacy and safety of inhaled iloprost in Japanese patients with pulmonary arterial hypertension - Insights from the IBUKI and AIR studies","volume":"80","author":"Saji","year":"2016","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0063|cit63","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A editor(s) GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. Updated October 2013 Available from gdt.gradepro.org\/app\/handbook\/handbook.html"},{"issue":"4","key":"10.1002\/14651858.CD012963.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD012963.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1203\/01.PDR.0000139927.86617.B6","article-title":"Aerosolized PGE1: a selective pulmonary vasodilator in neonatal hypoxemic respiratory failure results of a Phase I\/II open label clinical trial","volume":"56","author":"Sood","year":"2004","journal-title":"Pediatr Research"},{"issue":"5","key":"10.1002\/14651858.CD012963.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.pcl.2012.07.011","article-title":"Pharmacotherapy for pulmonary hypertension","volume":"59","author":"Steinhorn","year":"2012","journal-title":"Pediatric Clinics of North America"},{"issue":"3","key":"10.1002\/14651858.CD012963.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.acvd.2012.12.005","article-title":"Pathophysiology of persistent pulmonary hypertension of the newborn: impact of the perinatal environment","volume":"106","author":"Storme","year":"2013","journal-title":"Archives of Cardiovascular Diseases"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.12-2875","article-title":"Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial","volume":"144","author":"Tapson","year":"2013","journal-title":"Chest"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD012963.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1203\/00006450-199004000-00010","article-title":"Changes in the pulmonary circulation during birth-related events","volume":"27","author":"Teitel","year":"1990","journal-title":"Pediatric Research"},{"issue":"3","key":"10.1002\/14651858.CD012963.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/S0002-9149(99)80377-4","article-title":"Pharmacodynamic profile of prostacyclin","volume":"75","author":"Vane","year":"1995","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD012963.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1078-5884(03)00385-X","article-title":"Prostacyclin: a vascular mediator","volume":"26","author":"Vane","year":"2003","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"key":"10.1002\/14651858.CD012963.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/B978-1-4160-3995-2.10008-1","volume-title":"Neurology of the Newborn","author":"Volpe","year":"2008"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD012963.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.105.1.14","article-title":"Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes","volume":"105","author":"Walsh-Sukys","year":"2000","journal-title":"Pediatrics"},{"issue":"25","key":"10.1002\/14651858.CD012963.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1161\/01.CIR.102.25.3130","article-title":"Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells","volume":"102","author":"Wharton","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD012963.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/01.CIR.0000138104.83366.E9","article-title":"Outcomes in children with idiopathic pulmonary arterial hypertension","volume":"110","author":"Yung","year":"2004","journal-title":"Circulation"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012963.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T09:50:12Z","timestamp":1667901012000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012963.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neonatal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":75,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012963.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]}}}